Literature DB >> 9143413

Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer.

D M Provencher1, H Lounis, D Fink, P Drouin, A M Mes-Masson.   

Abstract

We performed a mutational analysis of the p53 gene in matched samples of solid tumors and ascites from patients with ovarian cancer using the single-strand conformation polymorphism technique on exons 5-9 of the p53 gene on fresh and cultured material. We observed a discordance in the pattern of p53 mutations between the ascites and their solid tumor counterpart. In two cases, cancer cells from ascites carried a p53 mutation and the corresponding solid tumor cells retained the wild-type allele, while the opposite pattern was observed in two other patients samples. These results suggest that ovarian tumor cells within the ascites may not simply represent cells shed from the ovarian solid tumor and bear directly on gene therapy strategies in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143413     DOI: 10.1159/000218027

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  2 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.

Authors:  James B Greenaway; Carl Virtanen; Kata Osz; Tamas Revay; Daniel Hardy; Trevor Shepherd; Gabriel DiMattia; Jim Petrik
Journal:  Oncotarget       Date:  2016-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.